Products Advantol 300

Advantol 300

Advantol® 300

Product information

INCI/Chemical Name:: Advantol® 300
SKU:: 37P0051

Documents

Didn't find the right document?

Available packs

Pack size

Stock

50.00 K DRUM

Request a quote

Request a sample

Advantol® is a robust, off-the-shelf excipient system that allows the formulator fast product development. It requires no special manufacturing equipment or tooling. Simply add the active to Advantol, dry blend and compress.

Would you like to know more?

Please sign in or request access to get access to the full content. In case you have any questions, please click the "Request information" button below.

New customer?

Request information

Discover our most recent inspiration articles

Knowledge

Miglyol 812N (C8/C10 ratio ~ 60:40%)

Migylol® 812 N MCT oils are high-quality pharma-grade lipids used in drug manufacturing for topical, capsule, droplet, and tincture applications.

2 months ago

2 min read

Grow your Know

Ensuring Fast Relief This Cold & Flu Season

Spikes in the flu and Cold cases are still expected for the winter season this year. Don't let shelves continue to be bare, be there.

3 months ago

4 min read

Market Trends

Directly compressible Spray-dried Lactose Monohydrate by Kerry

Directly compressible Spray-dried Lactose

3 months ago

6 min read

Product News

Newly Launched: S-Tab from SPI Pharma

S-Tab™, an innovative tablet platform from SPI Pharma, designed to transform pharmaceutical and nutritional direct compression tablets. With superior capabilities to enhance production rates, improve tablet properties, and expedite project development.

5 months ago

2 min read

Product News

Greenfield Global Product Listing from Azelis

Introducing Greenfield Global line of sustainably manufactured pharma grade solvents

7 months ago

1 min read

Product News

Protect Your Product with MULTISORB Sorbent Technology

Introducing the MULTISORB line of desiccant and oxygen absorbers for the optimum quality retention and shelf life extension of your formulas.

10 months ago

3 min read

See all articles